An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent ΔE1-E2-E3-E4 Ad5 vectors

被引:21
作者
Catalucci, D [1 ]
Sporeno, E [1 ]
Cirillo, A [1 ]
Ciliberto, G [1 ]
Nicosia, A [1 ]
Colloca, S [1 ]
机构
[1] Ist Ric Biol Mol P Angeletti, I-00040 Pomezia, Roma, Italy
关键词
D O I
10.1128/JVI.79.10.6400-6409.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced immunogenicity to adenovirus gene products requires the concomitant generation of efficient packaging cell lines. High expression levels of the complementing genes must be achieved in a coordinated fashion with viral replication. This is a particularly difficult task in light of the significant cytotoxicity displayed by adenoviral proteins. To this end, we developed a novel adenovirus-based amplicon with an Epstein-Barr virus origin of replication, Ad type 5 (Ad5) inverted terminal repeats, all Ad5 early region 2 (E2) genes, and the early region 4 (E4) open reading frame 6 (ORF6) under the control of a tetracycline-dependent promoter. The amplicon (pE2) was stably maintained in multiple copies in the nuclei of 293 cells stably expressing the Epstein-Barr virus nuclear antigen 1 (EBNA1) and allowed replication as a linear DNA upon induction of E2 and ORF6 gene expression. A stable cell line (M) was generated by introducing pE2 into 293EBNATet cells expressing the tetracycline-dependent transcriptional silencer and the reverse Tet transactivator (rtTA2). Upon induction with doxicycline, 2E2 cells produced higher levels of polymerase, precursor terminal protein (pTP), and DNA binding protein than noninduced 2E2 cells infected with first-generation Ad5 vector and supported efficient amplification of a multiply deleted Ad5 vector lacking E1, E2, E3, and E4 genes (Ad5 Delta E1-4). The high cloning capacity of Ad5 Delta E1-4 (up to 12.6 kb) was exploited to construct a vector encoding the entire hepatitis C virus (HCV) polyprotein. Infection of HeLa cells by the resulting vector showed high levels of correctly processed HCV proteins.
引用
收藏
页码:6400 / 6409
页数:10
相关论文
共 51 条
[31]   Regulation of adenovirus-mediated transgene expression by the viral E4 gene products:: Requirement for E4 ORF3 [J].
Lusky, M ;
Grave, L ;
Dieterlé, A ;
Dreyer, D ;
Christ, M ;
Ziller, C ;
Furstenberger, P ;
Kintz, J ;
Hadji, DA ;
Pavirani, A ;
Mehtali, M .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8308-8319
[32]   In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted [J].
Lusky, M ;
Christ, M ;
Rittner, K ;
Dieterle, A ;
Dreyer, D ;
Mourot, B ;
Schultz, H ;
Stoeckel, F ;
Pavirani, A ;
Mehtali, M .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2022-2032
[33]   Clinical trials - Gene therapy death prompts review of adenovirus vector [J].
Marshall, E .
SCIENCE, 1999, 286 (5448) :2244-2245
[34]   RESCUE, PROPAGATION, AND PARTIAL-PURIFICATION OF A HELPER VIRUS-DEPENDENT ADENOVIRUS VECTOR [J].
MITANI, K ;
GRAHAM, FL ;
CASKEY, CT ;
KOCHANEK, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3854-3858
[35]   EVALUATION OF THE EFFICACY AND SAFETY OF IN-VITRO, ADENOVIRUS-MEDIATED TRANSFER OF THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA [J].
MITTEREDER, N ;
YEI, SP ;
BACHURSKI, C ;
CUPPOLETTI, J ;
WHITSETT, JA ;
TOLSTOSHEV, P ;
TRAPNELL, BC .
HUMAN GENE THERAPY, 1994, 5 (06) :717-729
[36]   A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears [J].
Moorhead, JW ;
Clayton, GH ;
Smith, RL ;
Schaack, J .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1046-1053
[37]   An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene [J].
Morsy, MA ;
Gu, MC ;
Motzel, S ;
Zhao, J ;
Su, Q ;
Allen, H ;
Franlin, L ;
Parks, RJ ;
Graham, FL ;
Kochanek, S ;
Bett, AJ ;
Caskey, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :7866-7871
[38]   Expanded-capacity adenoviral vectors - the helper-dependent vectors [J].
Morsy, MA ;
Caskey, CT .
MOLECULAR MEDICINE TODAY, 1999, 5 (01) :18-24
[39]   A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal [J].
Parks, RJ ;
Chen, L ;
Anton, M ;
Sankar, U ;
Rudnicki, MA ;
Graham, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13565-13570
[40]   DEVELOPMENT AND ANALYSIS OF RECOMBINANT ADENOVIRUSES FOR GENE-THERAPY OF CYSTIC-FIBROSIS [J].
RICH, DP ;
COUTURE, LA ;
CARDOZA, LM ;
GUIGGIO, VM ;
ARMENTANO, D ;
ESPINO, PC ;
HEHIR, K ;
WELSH, MJ ;
SMITH, AE ;
GREGORY, RJ .
HUMAN GENE THERAPY, 1993, 4 (04) :461-476